TherapeuticsMD (TXMD) Capital Expenditures (2011 - 2022)
TherapeuticsMD's Capital Expenditures came in at -$21,000 for Q2 2022, compared with $41,000 a year earlier.
Powered by 
Analysis
TherapeuticsMD (TXMD) Capital Expenditures (2011 - 2022) Analysis & Trends
For FY2021, TherapeuticsMD's Capital Expenditures was $34,000, down 83.6% from FY2020.
- Capital Expenditures carries a five-year compound annual growth rate of -38.8% (FY2016 to FY2021).
- Going back by year, Capital Expenditures was $207,000 in FY2020 (-91.6%), $2.45 million in FY2019, $217,040 in FY2018 (+251.1%) and $61,817 in FY2017 (-84.4%).
- The five-year range for quarterly Capital Expenditures is -$70,000 (Q3 2021) to $996,909 (Q3 2019).
- Year-over-year, Capital Expenditures increased in two of the last five quarters, with growth averaging 146.9%.
- The fastest year-over-year change in Capital Expenditures over five years came in Q1 2019 (growth of 875.2%), and the weakest in Q2 2020 (a decline of 99.4%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 1.32 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 321.00 Mn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 1.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 533.00 Mn |
| 10 | TherapeuticsMD | 21.67 Mn | 21.67 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2022 | -21,000.00 |
| Mar 31, 2022 | 42,000.00 |
| Sep 30, 2021 | -70,000.00 |
| Jun 30, 2021 | 41,000.00 |
| Mar 31, 2021 | 63,000.00 |
| Dec 31, 2020 | 168,000.00 |
| Sep 30, 2020 | 13,000.00 |
| Jun 30, 2020 | 5,000.00 |
| Mar 31, 2020 | 21,000.00 |
| Dec 31, 2019 | 360,587.00 |
| Sep 30, 2019 | 996,909.00 |
| Jun 30, 2019 | 830,086.00 |
| Mar 31, 2019 | 262,418.00 |
| Dec 31, 2018 | 150,745.00 |
| Sep 30, 2018 | 20,575.00 |
| Jun 30, 2018 | 18,812.00 |
| Mar 31, 2018 | 26,908.00 |
| Dec 31, 2017 | 25,968.00 |
| Jun 30, 2017 | 8,015.00 |
| Mar 31, 2017 | 27,834.00 |
API Access
TherapeuticsMD Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=TXMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "TXMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=TXMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();